Epidemiology and prevention of hepatocellular carcinoma

Cancer Letters

Volumn 286, Issue 1, 2009, Pages 5-8

  Franceschi, Silvia ^a   Raza, Syed Ahsan ^a,b  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma; Meta analysis; Vaccine

Indexed keywords

HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE;

CANCER IMMUNIZATION; DRUG EFFICACY; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HIGH RISK POPULATION; HUMAN; LIVER CELL CARCINOMA; MIXED INFECTION; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SHORT SURVEY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 70350564911     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.10.046     Document Type: Review

References (28)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J. Clin. 55 (2005) 74-108
2. IARC, Monographs on the evaluation of carcinogenic risks to humans volume 59: hepatitis viruses, IARC Press, Lyon, 1994.
3. World Health Organisation. Hepatitis B vaccines. Wkly. Epidemiol. Rec. 79 (2004) 263
4. WHO and the Viral Hepatitis Prevention Board, Global surveillance and control of hepatitis C, Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium, J. Viral Hepat. 6 (1999) 35-47.
5. Parkin D.M. The global health burden of infection-associated cancers in the year 2002. Int. J. Cancer 118 (2006) 3030-3044
6. Lu S.N., Su W.W., Yang S.S., Chang T.T., Cheng K.S., Wu J.C., Lin H.H., Wu S.S., Lee C.M., Changchien C.S., Chen C.J., Sheu J.C., Chen D.S., and Chen C.H. Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int. J. Cancer 119 (2006) 1946-1952
7. Raza S.A., Clifford G.M., and Franceschi S. Worldwide variation in the relative importance of hepatitis B and hepatitis C viruses in hepatocellular carcinoma: a systematic review. Br. J. Cancer 96 (2007) 1127-1134
8. Shi J., Zhu L., Liu S., and Xie W.F. A meta-analysis of case-control studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma in China. Br. J. Cancer 92 (2005) 607-612
9. Tanioka H., Omagari K., Kato Y., Nakata K., Kusumoto Y., Mori I., Furukawa R., Tajima H., Koga M., Yano M., and Kohno S. Present status of hepatitis virus-associated hepatocellular carcinoma in Nagasaki Prefecture, Japan: a cross-sectional study of 1019 patients. J. Infect. Chemother. 8 (2002) 64-69
10. Donato F., Gelatti U., Limina R.M., and Fattovich G. Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence. Oncogene 25 (2006) 3756-3770
11. Franceschi S., Montella M., Polesel J., La Vecchia C., Crispo A., Dal Maso L., Casarin P., Izzo F., Tommasi L.G., Chemin I., Trepo C., Crovatto M., and Talamini R. Hepatitis viruses, alcohol, and tobacco in the etiology of hepatocellular carcinoma in Italy. Cancer Epidemiol. Biomarkers Prev. 15 (2006) 683-689
12. Kuper H.E., Tzonou A., Kaklamani E., Hadziyannis S., Tasopoulos N., Lagiou P., Trichopoulos D., and Stuver S. Hepatitis B and C viruses in the etiology of hepatocellular carcinoma; a study in Greece using third-generation assays. Cancer Causes Control 11 (2000) 171-175
13. Kubicka S., Rudolph K.L., Hanke M., Tietze M.K., Tillmann H.L., Trautwein C., and Manns M. Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area. Liver 20 (2000) 312-318
14. Davila J.A., Morgan R.O., Shaib Y., McGlynn K.A., and El-Serag H.B. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study. Gastroenterology 127 (2004) 1372-1380
15. Ezzat S., Abdel-Hamid M., Eissa S.A., Mokhtar N., Labib N.A., ElGhorory L., Mikhail N.N., Abdel-Hamid A., Hifnawy T., Strickland G.T., and Loffredo C.A. Associations of pesticides, HCV, HBV, and hepatocellular carcinoma in Egypt. Int. J. Hyg. Environ. Health 208 (2005) 329-339
16. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., and Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol. Rev. 28 (2006) 112-125
17. Viviani S., Jack A., Hall A.J., Maine N., Mendy M., Montesano R., and Whittle H.C. Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age. Vaccine 17 (1999) 2946-2950
18. Institute of Medicine, Immunization Safety Review Board, in: K.R. Stratton, D.A. Almario, M.C. McCormick (Eds.), Immunization Safety Review: Hepatitis B Vaccine and Demyelinating Neurological Disorders, National Academies Press, Washington, DC, 2003.
19. Lee C.L., Hsieh K.S., and Ko Y.C. Trends in the incidence of hepatocellular carcinoma in boys and girls in Taiwan after large-scale hepatitis B vaccination. Cancer Epidemiol. Biomarkers Prev. 12 (2003) 57-59
20. Sun Z., Zhu Y., Stjernsward J., Hilleman M., Collins R., Zhen Y., Hsia C.C., Lu J., Huang F., and Ni Z. Design and compliance of HBV vaccination trial on newborns to prevent hepatocellular carcinoma and 5-year results of its pilot study. Cancer Detect. Prev. 15 (1991) 313-318
21. Elmowalid G.A., Qiao M., Jeong S.H., Borg B.B., Baumert T.F., Sapp R.K., Hu Z., Murthy K., and Liang T.J. Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees. Proc. Natl. Acad. Sci. USA 104 (2007) 8427-8432
22. Ahmad K. Pakistan: a cirrhotic state?. Lancet 364 (2004) 1843-1844
23. La Vecchia C. Alcohol and liver cancer. Eur. J. Cancer Prev. 16 (2007) 495-497
24. Yuan J.M., Govindarajan S., Arakawa K., and Yu M.C. Synergism of alcohol, diabetes, and viral hepatitis on the risk of hepatocellular carcinoma in blacks and whites in the U.S. Cancer 101 (2004) 1009-1017
25. Amin J., Dore G.J., O'Connell D.L., Bartlett M., Tracey E., Kaldor J.M., and Law M.G. Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study. J. Hepatol. 45 (2006) 197-203
26. Knoll A., Hartmann A., Hamoshi H., Weislmaier K., and Jilg W. Serological pattern "anti-HBc alone": characterization of 552 individuals and clinical significance. World J. Gastroenterol. 12 (2006) 1255-1260
27. World Health Organisation. Hepatitis C-global prevalence (update). Wkly. Epidemiol. Rec. 49 (1999) 425-427
28. Madhava V., Burgess C., and Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect. Dis. 2 (2002) 293-302